These two institutions add substantial strength and expertise to the excellence of cancer care, research, and education characteristic of the other 21 world-class member institutions.
—Robert W. Carlson, MD
The National Comprehensive Cancer Network (NCCN) recently announced the addition of two new NCCN Member Institutions: UC San Diego Moores Cancer Center in La Jolla, California, and the University of Colorado Cancer Center in Aurora, Colorado.
“We are extremely pleased that UC San Diego Moores Cancer Center and the University of Colorado Cancer Center have been elected to institutional membership in NCCN,” said Robert W. Carlson, MD, CEO of NCCN. “These two institutions add substantial strength and expertise to the excellence of cancer care, research, and education characteristic of the other 21 world-class member institutions.”
UC San Diego Moores Cancer Center
Established in 1977, the UC San Diego Moores Cancer Center is one of just 41 National Cancer Institute (NCI)–designated comprehensive cancer centers in the United States, and the only one in the San Diego region. “We are thrilled to join NCCN,” said Scott M. Lippman, MD, Director, UC San Diego Moores Cancer Center. “NCCN and UC San Diego share a mission to save lives through bringing the most effective therapeutic and prevention strategies to cancer patients. We look forward to working with fellow premier NCCN institutions to impact the outcomes of cancer care and to influence the direction of the cancer field.”
University of Colorado Cancer Center
The University of Colorado Cancer Center is Colorado’s only NCI-designated comprehensive cancer center. The center is a consortium of three state universities, including the University of Colorado (CU) in Boulder and University of Colorado in Denver, and six institutions (University of Colorado Health, Children’s Hospital Colorado, Denver Health, Denver VA Medical Center, Kaiser Permanente Colorado, and National Jewish Health).
University of Colorado Hospital (UCH) is the primary adult teaching hospital and where the majority of CU Cancer Center clinical care is delivered and research is conducted.
“We are honored and humbled by being elected to institutional membership by NCCN,” said Dan
Theodorescu, MD, PhD, Director, CU Cancer Center. “NCCN has been a national leader in advancing the quality and practice of cancer medicine. We look forward to contributing our expertise and ideas while supporting NCCN’s national and international initiatives in patient care and research.” ■